D. P. Aden, A. Fogel, S. Plotkin, I. Damjanov, and B. B. Knowles, Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line, Nature, vol.259, issue.5739, pp.615-621, 1979.
DOI : 10.1038/bjc.1976.205

D. Amadori, L. Bertoni, A. Flamigni, S. Savini, C. De-giovanni et al., Establishment and characterization of a new cell line from primary human breast carcinoma, Breast Cancer Research and Treatment, vol.50, issue.3, pp.251-260, 1993.
DOI : 10.1007/BF00666586

G. M. Arantes, The Catalytic Acid in the Dephosphorylation of the Cdk2-pTpY/CycA Protein Complex by Cdc25B Phosphatase, The Journal of Physical Chemistry B, vol.112, issue.47, pp.15244-15251, 2008.
DOI : 10.1021/jp8070019

B. Aressy and B. Ducommun, Cell Cycle Control by the CDC25 Phosphatases. Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents), p.7, 2008.

C. Asche and . Antitumour-quinones, Mini reviews in medicinal chemistry, pp.449-67, 2005.

T. Ashihara and R. Baserga, [20] Cell synchronization, Methods in Enzymology, vol.58, pp.248-262, 1979.
DOI : 10.1016/S0076-6879(79)58141-5

P. Astuti and B. Gabrielli, Phosphorylation of Cdc25B3 Ser169 regulates 14-3-3 binding to Ser151 and Cdc25B activity, Cell Cycle, vol.10, issue.12, pp.1960-1967, 2011.
DOI : 10.4161/cc.10.12.15819

S. Bäurle, T. Blume, J. Günther, D. Henschel, R. C. Hillig et al., Design and Synthesis of Macrocyclic Inhibitors of Phosphatase Cdc25B., ChemInform, vol.14, issue.34, pp.1673-1680, 2004.
DOI : 10.1002/chin.200434105

A. Beillerot, E. Battaglia, B. Aline, and D. Bagrel, Protection of CDC25 phosphatases against oxidative stress in breast cancer cells: Evaluation of the implication of the thioredoxin system, Free Radical Research, vol.407, issue.5, pp.674-89, 2012.
DOI : 10.1016/j.bbrc.2011.02.133

D. A. Berry, C. Cirrincione, I. C. Henderson, M. L. Citron, D. R. Budman et al., Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer, JAMA, vol.295, issue.14, pp.1658-67, 2006.
DOI : 10.1001/jama.295.14.1658

A. L. Blajeski, V. A. Phan, T. J. Kottke, and S. H. Kaufmann, G1 and G2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells, Journal of Clinical Investigation, vol.110, issue.1, pp.91-99, 2002.
DOI : 10.1172/JCI13275

C. Blanc, Q. L. Deveraux, S. Krajewski, R. U. Jänicke, A. G. Porter et al., Caspase-3 is essential for procaspase-9 processing and cisplatininduced apoptosis of MCF-7 breast cancer cells, Cancer research, vol.60, issue.16, pp.4386-90, 2000.

A. Blasina, I. V. De-weyer, M. C. Laus, W. H. Luyten, A. E. Parker et al., A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase, Current Biology, vol.9, issue.1, pp.1-10, 1999.
DOI : 10.1016/S0960-9822(99)80041-4

I. Blomberg and I. Hoffmann, /S Transition and Leads to Premature Activation of Cyclin E- and Cyclin A-Dependent Kinases, Molecular and Cellular Biology, vol.19, issue.9, pp.6183-94, 1999.
DOI : 10.1128/MCB.19.9.6183

B. Iii-bonin, S. Brunetti, D. Benedetti, E. Gorji, N. Stanta et al., Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer, Virchows Archiv, vol.1, issue.5, pp.539-544, 2006.
DOI : 10.1177/153303460200100410

R. Boutros, C. Dozier, and B. Ducommun, The when and wheres of CDC25 phosphatases, Current Opinion in Cell Biology, vol.18, issue.2, pp.185-191, 2006.
DOI : 10.1016/j.ceb.2006.02.003

URL : https://hal.archives-ouvertes.fr/hal-00317392

R. Boutros, V. Lobjois, and B. Ducommun, CDC25 phosphatases in cancer cells: key players? Good targets?, Nature Reviews Cancer, vol.20, issue.7, pp.495-507, 2007.
DOI : 10.1158/0008-5472.CAN-05-1054

URL : https://hal.archives-ouvertes.fr/hal-00317350

D. C. Brady-west and D. A. Mcgrowder, Triple negative breast cancer: therapeutic and prognostic implications. Asian Pacific journal of cancer prevention, APJCP, vol.12, issue.8, pp.2139-2182, 2011.

E. Braud, M. Goddard, S. Kolb, M. Brun, O. Mondésert et al., Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties, Bioorganic & Medicinal Chemistry, vol.16, issue.19, pp.9040-9049, 2008.
DOI : 10.1016/j.bmc.2008.08.009

L. Brault and D. Bagrel, Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells, Life Sciences, vol.82, issue.5-6, pp.5-6, 2008.
DOI : 10.1016/j.lfs.2007.12.001

L. Brault, M. Denancé, E. Banaszak, S. Maadidi, E. Battaglia et al., Synthesis and biological evaluation of dialkylsubstituted maleic anhydrides as novel inhibitors of Cdc25 dual specificity phosphatases, European Journal of Medicinal Chemistry, vol.42, issue.2, pp.243-247, 2007.
DOI : 10.1016/j.ejmech.2006.09.014

P. Auvray, P. G. Kasprzyk, G. P. Prevost, and B. Ducommun, Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases, Molecular Cancer Therapeutics, vol.4, issue.9, pp.1378-1387, 2005.

G. P. Prevost and B. Ducommun, A novel synthetic inhibitor of CDC25 phosphatases: BN82002, Cancer Research, vol.64, issue.9, pp.3320-3325, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00317444

M. C. Brezak, A. Valette, M. Quaranta, M. O. Contour-galcera, D. Jullien et al., IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells, International Journal of Cancer, vol.29, issue.6, pp.1449-1456, 2009.
DOI : 10.4161/cc.7.2.5306

M. Brezak, P. G. Kasprzyk, M. Galcera, O. Lavergne, and G. P. Prévost, CDC25 inhibitors as anticancer agents are moving forward. Anti-cancer agents in medicinal chemistry, pp.857-62, 2008.
DOI : 10.2174/187152008786847701

M. Brisson, T. Nguyen, A. Vogt, J. Yalowich, A. Giorgianni et al., Discovery and Characterization of Novel Small Molecule Inhibitors of Human Cdc25B Dual Specificity Phosphatase, Molecular Pharmacology, vol.66, issue.4, pp.824-833, 2004.
DOI : 10.1124/mol.104.001784

B. Iv-brisson, M. Foster, C. Wipf, P. Joo, B. Tomko et al., Independent Mechanistic Inhibition of Cdc25 Phosphatases by a Natural Product Caulibugulone, Molecular Pharmacology, vol.71, issue.1, pp.184-92, 2007.
DOI : 10.1124/mol.106.028589

M. P. Brun, E. Braud, D. Angotti, O. Mondesert, M. Quaranta et al., Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity, Bioorganic & Medicinal Chemistry, vol.13, issue.16, pp.4871-4879, 2005.
DOI : 10.1016/j.bmc.2005.05.005

URL : https://hal.archives-ouvertes.fr/hal-00317419

E. Appella and A. J. Fornace, Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase, Nature, vol.411, issue.6833, pp.102-109, 2001.

D. Bulavin, Y. Higashimoto, Z. N. Demidenko, S. Meek, P. Graves et al., Dual phosphorylation controls Cdc25 phosphatases and mitotic entry, Nature Cell Biology, vol.36, issue.6, pp.545-51, 2003.
DOI : 10.1016/S0091-679X(08)60298-8

M. Bureik, N. Rief, R. Drescher, A. Jungbluth, M. Montenarh et al., An additional transcript of the cdc25C gene from A431 cells encodes a functional protein., International Journal of Oncology, vol.17, issue.6, pp.1251-1259, 2000.
DOI : 10.3892/ijo.17.6.1251

L. Busino, M. Chiesa, G. F. Draetta, and M. Donzelli, Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis, Oncogene, vol.23, issue.11, pp.2050-2056, 2004.
DOI : 10.1126/science.280.5363.593

R. Cailleau, R. Young, M. Olive, and W. J. Reeves-jr, Breast Tumor Cell Lines From Pleural Effusions 2, JNCI: Journal of the National Cancer Institute, vol.53, issue.3, pp.661-674, 1974.
DOI : 10.1093/jnci/53.3.661

M. G. Cangi, B. Cukor, P. Soung, S. Signoretti, G. Moreira-jr et al., Role of the Cdc25A phosphatase in human breast cancer, Journal of Clinical Investigation, vol.106, issue.6, pp.753-761, 2000.
DOI : 10.1172/JCI9174

S. Cao, C. Foster, J. S. Lazo, and D. G. Kingston, Sesterterpenoids and an alkaloid from a Thorectandra sp. as inhibitors of the phosphatase Cdc25B, Bioorganic & Medicinal Chemistry, vol.13, issue.17, pp.5094-5102, 2005.
DOI : 10.1016/j.bmc.2005.04.070

S. Cao, C. Foster, J. S. Lazo, and D. G. Kingston, Four diterpenoid inhibitors of Cdc25B phosphatase from a marine anemone, Bioorganic & Medicinal Chemistry, vol.13, issue.20, pp.5830-5834, 2005.
DOI : 10.1016/j.bmc.2005.05.057

P. Carmeliet and R. K. Jain, Angiogenesis in cancer and other diseases, Nature, vol.407, issue.6801, pp.249-57, 2000.
DOI : 10.1038/35025220

M. Cazales, R. Boutros, M. Brezak, S. Chaumeron, G. Prevost et al., Pharmacologic inhibition of CDC25 phosphatases impairs interphase microtubule dynamics and mitotic spindle assembly, Molecular Cancer Therapeutics, vol.6, issue.1, pp.318-343, 2007.
DOI : 10.1158/1535-7163.MCT-06-0299

URL : https://hal.archives-ouvertes.fr/hal-00317361

M. Chen, C. E. Ryan, and H. Piwnica-worms, Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding, Molecular and Cellular Biology, vol.23, issue.21, pp.7488-97, 2003.
DOI : 10.1128/MCB.23.21.7488-7497.2003

S. Choi, J. Kim, N. Sung, K. Son, H. Cheon et al., Thunb., Natural Product Research, vol.21, issue.6, pp.487-93, 2007.
DOI : 10.1074/jbc.M410984200

G. M. Cohen and M. Doherty, Free radical mediated cell toxicity by redox cycling chemicals, British Journal of Cancer Supplement, vol.8, pp.46-52, 1987.

D. S. Conklin, K. Galaktionov, and D. Beach, 14-3-3 proteins associate with cdc25 phosphatases., Proceedings of the National Academy of Sciences, vol.92, issue.17, pp.7892-7898, 1995.
DOI : 10.1073/pnas.92.17.7892

M. O. Contour-galcera, A. Sidhu, G. Prevost, D. Bigg, and B. Ducommun, What's new on CDC25 phosphatase inhibitors, Pharmacology & Therapeutics, vol.115, issue.1, pp.1-12, 2007.
DOI : 10.1016/j.pharmthera.2007.03.009

M. D. Crespi, S. E. Ivanier, J. Genovese, and A. Baldi, Mitoxantrone affects topoisomerase activities in human breast cancer cells, Biochemical and Biophysical Research Communications, vol.136, issue.2, pp.521-528, 1986.
DOI : 10.1016/0006-291X(86)90471-7

D. 'hondt, V. Piccart, M. Sotiriou, and C. , Introduire les profils d'expression génomiques en clinique: à quand les signatures moléculaires au lit du malade?, Bulletin du cancer, vol.95, issue.3, pp.336-343, 2008.

G. Deep and R. Agarwal, New combination therapies with cell-cycle agents, Current opinion in investigational drugs, vol.9, issue.6, pp.2000-591, 2008.

G. Deep, N. H. Oberlies, D. J. Kroll, and R. Agarwal, Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells, International Journal of Cancer, vol.36, issue.1, pp.41-50, 2008.
DOI : 10.1007/978-1-4615-4253-7_10

A. R. Demidova, M. Y. Aau, L. Zhuang, and Q. Yu, Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control, Journal of Biological Chemistry, vol.269, issue.7, pp.4132-4141, 2009.
DOI : 10.1073/pnas.0505585102

K. Dodo, M. Takahashi, Y. Yamada, Y. Sugimoto, Y. Hashimoto et al., Synthesis of a novel class of cdc25A inhibitors from vitamin D 3, Bioorganic & Medicinal Chemistry Letters, vol.10, issue.7, pp.615-617, 2000.
DOI : 10.1016/S0960-894X(00)00065-2

M. Donzelli and G. F. Draetta, Regulating mammalian checkpoints through Cdc25 inactivation, EMBO Reports, vol.4, issue.7, pp.671-678, 2003.
DOI : 10.1038/sj.embor.embor887

B. Vi-donzelli, M. Squatrito, M. Ganoth, D. Hershko, A. Pagano et al., Dual mode of degradation of Cdc25 A phosphatase, The EMBO Journal, vol.21, issue.18, pp.4875-84, 2002.
DOI : 10.1093/emboj/cdf491

G. Dranoff, Cytokines in cancer pathogenesis and cancer therapy, Nature Reviews Cancer, vol.7, issue.1, pp.11-22, 2004.
DOI : 10.1038/nm1001-1118

I. S. Elefsiniotis, K. D. Pantazis, A. Ilias, L. Pallis, A. Mariolis et al., Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis, European Journal of Gastroenterology & Hepatology, vol.16, issue.6, pp.593-601, 2004.
DOI : 10.1097/00042737-200406000-00013

J. Falck, N. Mailand, R. G. Syljuåsen, J. Bartek, and J. Lukas, The ATM???Chk2???Cdc25A checkpoint pathway guards against radioresistant DNA synthesis, Nature, vol.20, issue.6830, pp.842-849, 2001.
DOI : 10.1128/MCB.20.10.3497-3509.2000

E. B. Fauman, J. P. Cogswell, B. Lovejoy, W. J. Rocque, W. Holmes et al., Crystal Structure of the Catalytic Domain of the Human Cell Cycle Control Phosphatase, Cdc25A, Crystal structure of the catalytic domain of the human cell cycle control phosphatase, pp.617-642, 1998.
DOI : 10.1016/S0092-8674(00)81190-3

E. B. Fauman and M. A. Saper, Structure and function of theprotein tyrosine phosphatases, Trends in Biochemical Sciences, vol.21, issue.11, pp.413-417, 1996.
DOI : 10.1016/S0968-0004(96)10059-1

A. M. Ferguson, L. S. White, P. J. Donovan, and H. Piwnica-worms, Normal Cell Cycle and Checkpoint Responses in Mice and Cells Lacking Cdc25B and Cdc25C Protein Phosphatases, Molecular and Cellular Biology, vol.25, issue.7, pp.2853-2860, 2005.
DOI : 10.1128/MCB.25.7.2853-2860.2005

B. G. Gabrielli, C. P. De-souza, I. D. Tonks, J. M. Clark, N. K. Hayward et al., Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells, Journal of Cell Science, vol.109, issue.5, pp.1081-1093, 1996.

K. Galaktionov, X. Chen, and D. Beach, Cdc25 cell-cycle phosphatase as a target of c-myc, Nature, vol.382, issue.6591, pp.511-518, 1996.
DOI : 10.1038/382511a0

K. Galaktionov, A. K. Lee, J. Eckstein, G. Draetta, J. Meckler et al., CDC25 phosphatases as potential human oncogenes, CDC25 phosphatases as potential human oncogenes, pp.1575-1582, 1995.
DOI : 10.1126/science.7667636

P. A. Garner-hamrick and C. Fisher, Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects, International Journal of Cancer, vol.271, issue.5, pp.720-728, 1998.
DOI : 10.1074/jbc.271.9.5118

A. F. Gazdar, V. Kurvari, A. Virmani, L. Gollahon, M. Sakaguchi et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, International Journal of Cancer, vol.24, issue.6, pp.766-774, 1998.
DOI : 10.1007/BF01047461

N. Giles, A. Forrest, and B. Gabrielli, 14-3-3 Acts as an Intramolecular Bridge to Regulate cdc25B Localization and Activity, Journal of Biological Chemistry, vol.19, issue.31, pp.31-28580, 2003.
DOI : 10.1038/sj.onc.1206107

B. Vii-gunasekera, S. P. Mccarthy, P. J. Kelly-borges, M. Lobkovsky, E. Clardy et al., de Laubenfels, Journal of the American Chemical Society, vol.118, issue.36, pp.8759-8760, 1996.
DOI : 10.1021/ja961961+

J. Guo, J. Kleeff, J. Li, J. Ding, J. Hammer et al., Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinoma, Oncogene, vol.23, issue.1, pp.71-81, 2004.
DOI : 10.1006/dbio.1995.1207

S. W. Ham, J. Park, S. J. Lee, W. Kim, K. Kang et al., Naphthoquinone analogs as inactivators of cdc25 phosphatase, Bioorganic & Medicinal Chemistry Letters, vol.8, issue.18, pp.2507-2510, 1998.
DOI : 10.1016/S0960-894X(98)00411-9

S. W. Ham and B. I. Carr, Cell Division Cycle 25 (Cdc25) Phosphatase Inhibitors as Antitumor Agents, Drug Design Reviews - Online, vol.1, issue.2, p.10, 2004.
DOI : 10.2174/1567269043480618

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

S. Hernández, L. Hernández, S. Beà, M. Cazorla, P. L. Fernández et al., cdc25 cell cycleactivating phosphatases and c-myc expression in human non-Hodgkin's lymphomas, Cancer research, vol.58, issue.8, pp.1762-1769, 1998.

F. Hirschhaeuser, H. Menne, C. Dittfeld, J. West, W. Mueller-klieser et al., Multicellular tumor spheroids: An underestimated tool is catching up again, Journal of Biotechnology, vol.148, issue.1, pp.3-15, 2010.
DOI : 10.1016/j.jbiotec.2010.01.012

H. Hochegger, S. Takeda, and T. Hunt, Cyclin-dependent kinases and cell-cycle transitions: does one fit all?, Nature Reviews Molecular Cell Biology, vol.10, issue.11, pp.910-916, 2008.
DOI : 10.1128/MCB.19.10.7011

I. Hoffmann and E. Karsenti, The role of cdc25 in checkpoints and feedback controls in the eukaryotic cell cycle, Journal of Cell Science, vol.1994, issue.Supplement 18, pp.75-79, 1994.
DOI : 10.1242/jcs.1994.Supplement_18.11

Y. Ishihara, S. Ishii, Y. Sakai, N. Yamamura, Y. Onishi et al., Crucial role of cytochrome P450 in hepatotoxicity induced by 2,3-dimethoxy-1,4-naphthoquinone in rats, Journal of Applied Toxicology, vol.31, issue.7, pp.173-181, 2011.
DOI : 10.1002/jat.1578

Y. Ishihara and N. Shimamoto, A Role of Cytochrome P450 in Quinone-Induced Hepatotoxicity, Hepatotoxicity, vol.10, pp.10-1002, 2007.
DOI : 10.1002/9780470516751.ch10

Y. Ito, H. Yoshida, F. Matsuzuka, N. Matsuura, Y. Nakamura et al., Cdc25A and cdc25B expression in malignant lymphoma of the thyroid: Correlation with histological subtypes and cell proliferation, International Journal of Molecular Medicine, vol.13, issue.3, pp.431-436, 2004.
DOI : 10.3892/ijmm.13.3.431

B. Viii-izumi, T. Maller, and J. L. , Phosphorylation and activation of the Xenopus Cdc25 phosphatase in the absence of Cdc2 and Cdk2 kinase activity., Molecular Biology of the Cell, vol.6, issue.2, pp.215-226, 1995.
DOI : 10.1091/mbc.6.2.215

R. U. Jänicke, M. L. Sprengart, M. R. Wati, and A. G. Porter, Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis, Journal of Biological Chemistry, vol.15, issue.16, pp.9357-60, 1998.
DOI : 10.1038/384368a0

Z. Jiang and Z. Zhang, Targeting PTPs with small molecule inhibitors in cancer treatment, Cancer and Metastasis Reviews, vol.282, issue.Suppl 2, pp.263-72, 2008.
DOI : 10.1128/MCB.14.6.3752

H. Jiao, S. L. Allinson, M. J. Walsh, R. Hewitt, K. J. Cole et al., Growth kinetics in MCF-7 cells modulate benzo[a]pyrene-induced CYP1A1 up-regulation, Mutagenesis, vol.22, issue.2, pp.111-116, 2007.
DOI : 10.1093/mutage/gel060

S. Jinno, K. Suto, A. Nagata, M. Igarashi, Y. Kanaoka et al., Cdc25A is a novel phosphatase functioning early in the cell cycle, Embo J, vol.13, issue.7, pp.1549-1556, 1994.

D. Jullien, B. Bugler, C. Dozier, M. Cazales, and B. Ducommun, Identification of N-Terminally Truncated Stable Nuclear Isoforms of CDC25B That Are Specifically Involved in G2/M Checkpoint Recovery, Cancer Research, vol.71, issue.5, pp.1968-77, 2011.
DOI : 10.1158/0008-5472.CAN-10-2453

J. Kapuscinski and Z. Darzynkiewicz, Relationship between the pharmacological activity of antitumor drugs Ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids., Proceedings of the National Academy of Sciences, vol.83, issue.17, pp.6302-6308, 1986.
DOI : 10.1073/pnas.83.17.6302

S. Kar, M. Wang, and B. I. Carr, 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis, Cancer Chemotherapy and Pharmacology, vol.24, issue.2080, pp.831-840, 2008.
DOI : 10.4161/cbt.5.10.3223

S. Kar, M. Wang, W. Yao, C. J. Michejda, and B. I. Carr, PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo, Molecular Cancer Therapeutics, vol.5, issue.6, pp.1511-1520, 2006.
DOI : 10.1158/1535-7163.MCT-05-0485

C. Karlsson, S. Katich, A. Hagting, I. Hoffmann, and J. Pines, Cdc25b and Cdc25c Differ Markedly in Their Properties as Initiators of Mitosis, The Journal of Cell Biology, vol.124, issue.3, pp.573-84, 1999.
DOI : 10.1101/gad.12.14.2131

T. Kayashima, M. Mori, R. Mizutani, K. Nishio, K. Kuramochi et al., Synthesis and biological evaluation of vitamin K derivatives as angiogenesis inhibitor, Bioorganic & Medicinal Chemistry, vol.18, issue.17, pp.6305-6314, 2010.
DOI : 10.1016/j.bmc.2010.07.022

K. Keyomarsi, L. Sandoval, V. Band, and A. B. Pardee, Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin, Cancer research, vol.51, issue.13, pp.3602-3609, 1991.

J. B. Kim, M. J. O-'hare, and R. Stein, Models of breast cancer: is merging human and animal models the future?, Breast Cancer Research, vol.77, issue.1, pp.22-30, 2004.
DOI : 10.1038/bjc.1998.96

B. Ix-kim, K. S. Kawasaki, I. Chong, Y. Shim, and Y. , Inhibition of overexpressed CDC-25.1 phosphatase activity by flavone in Caenorhabditis elegans, Molecules and Cells, vol.46, issue.3, pp.345-50, 2009.
DOI : 10.1007/s10059-009-0044-9

C. Hoelzl, J. Bichler, and B. J. Majer, Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge, Toxicology, vol.198, pp.1-3, 2004.

H. Kojima, N. Nakatsubo, K. Kikuchi, Y. Urano, T. Higuchi et al., Direct evidence of NO production in rat hippocampus and cortex using a new fluorescent indicator, NeuroReport, vol.9, issue.15, pp.3345-3353, 1998.
DOI : 10.1097/00001756-199810260-00001

S. Kolb, O. Mondésert, M. Goddard, D. Jullien, B. O. Villoutreix et al., Development of Novel Thiazolopyrimidines as CDC25B Phosphatase Inhibitors, ChemMedChem, vol.49, issue.4, pp.633-648, 2009.
DOI : 10.4161/cc.7.2.5306

K. Kristjansdottir, J. Rudolph, K. Kristja, and N. Carolina, Cdc25 Phosphatases and Cancer, Chemistry & Biology, vol.11, issue.8, pp.1043-1051, 2004.
DOI : 10.1016/j.chembiol.2004.07.007

M. Lacroix and G. Leclercq, Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update, Breast Cancer Research and Treatment, vol.20, issue.3, pp.249-289, 2004.
DOI : 10.1038/bjc.1988.245

A. Lacy and R. Kennedy, Studies on Coumarins and Coumarin-Related Compounds to Determine their Therapeutic Role in the Treatment of Cancer, Current Pharmaceutical Design, vol.10, issue.30, pp.3797-811, 2004.
DOI : 10.2174/1381612043382693

B. G. Lake, Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food and chemical toxicology : an international journal published for the, British Industrial Biological Research Association, vol.37, issue.4, pp.423-53, 1999.

D. W. Lamson and S. M. Plaza, The anticancer effects of vitamin K. Alternative medicine review : a journal of clinical therapeutic, pp.303-321, 2003.

A. Lavecchia, C. Giovanni, . Di, and E. Novellino, CDC25 phosphatase inhibitors: an update. Mini reviews in medicinal chemistry, pp.62-73, 2012.

A. Lavecchia, C. Di-giovanni, and E. Novellino, CDC25A and B Dual-Specificity Phosphatase Inhibitors: Potential Agents for Cancer Therapy, Current Medicinal Chemistry, vol.16, issue.15, pp.1831-1880, 2009.
DOI : 10.2174/092986709788186084

A. Lavecchia, C. Di-giovanni, and E. Novellino, Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review, Expert Opinion on Therapeutic Patents, vol.303, issue.3, pp.405-430, 2010.
DOI : 10.1126/science.1092472

A. Lavecchia, C. Di-giovanni, A. Pesapane, N. Montuori, P. Ragno et al., Discovery of New Inhibitors of Cdc25B Dual Specificity Phosphatases by Structure-Based Virtual Screening, Journal of Medicinal Chemistry, vol.55, issue.9, pp.4142-58, 2012.
DOI : 10.1021/jm201624h

J. S. Lazo, K. Nemoto, K. E. Pestell, K. Cooley, E. C. Southwick et al., Identification of a Potent and Selective Pharmacophore for Cdc25 Dual Specificity Phosphatase Inhibitors., Molecular Pharmacology, vol.61, issue.4, pp.720-728, 2002.
DOI : 10.1124/mol.61.4.720

C. P. Lebel, H. Ischiropoulos, and S. C. Bondy, Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress, Chemical Research in Toxicology, vol.5, issue.2, pp.227-231, 1992.
DOI : 10.1021/tx00026a012

W. C. Liao, F. Y. Wu, and C. W. Wu, Binary/ternary combined effects of vitamin K3 with other antitumor agents in nasopharyngeal carcinoma CG1 cells., International Journal of Oncology, vol.17, issue.2, pp.323-331, 2000.
DOI : 10.3892/ijo.17.2.323

A. J. Lincoln, D. Wickramasinghe, P. Stein, R. M. Schultz, M. E. Palko et al., Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation, Nature Genetics, vol.30, issue.4, pp.446-449, 2002.
DOI : 10.1038/ng856

A. Lindqvist, H. Källström, and C. Karlsson-rosenthal, Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress, Journal of Cell Science, vol.117, issue.21, pp.4979-90, 2004.
DOI : 10.1242/jcs.01395

S. E. Lipshultz, N. Rifai, V. M. Dalton, D. E. Levy, L. B. Silverman et al., The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia, New England Journal of Medicine, vol.351, issue.2, pp.145-53, 2004.
DOI : 10.1056/NEJMoa035153

H. Löffler, R. G. Syljuåsen, J. Bartkova, J. Worm, J. Lukas et al., Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines, Oncogene, vol.22, issue.50, pp.8063-71, 2003.
DOI : 10.1038/35044005

J. S. Lopez-gonzalez, H. Prado-garcia, D. Aguilar-cazares, J. A. Molina-guarneros, J. Morales-fuentes et al., Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines, Lung Cancer, vol.43, issue.3, pp.275-83, 2004.
DOI : 10.1016/j.lungcan.2003.09.005

J. W. Lown, The mechanism of action of quinone antibiotics, Molecular and Cellular Biochemistry, vol.55, issue.1, pp.17-40, 1983.
DOI : 10.1007/BF00229240

J. Lown, C. Hanstock, R. Bradley, and D. Scraba, Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy, Mol. Pharmacol, vol.25, issue.1, pp.178-184, 1984.

J. P. Mackeigan, L. O. Murphy, and J. Blenis, Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance, Nature Cell Biology, vol.7, issue.6, pp.591-600, 2005.
DOI : 10.1016/j.ccr.2005.01.010

N. Mailand, A. V. Podtelejnikov, A. Groth, M. Mann, J. Bartek et al., Regulation of G2/M events by Cdc25A through phosphorylation-dependent modulation of its stability, The EMBO Journal, vol.21, issue.21, pp.5911-5931, 2002.
DOI : 10.1093/emboj/cdf567

I. A. Manke, A. Nguyen, D. Lim, M. Q. Stewart, A. E. Elia et al., MAPKAP Kinase-2 Is a Cell Cycle Checkpoint Kinase that Regulates the G2/M Transition and S Phase Progression in Response to UV Irradiation, Molecular Cell, vol.17, issue.1, pp.37-48, 2005.
DOI : 10.1016/j.molcel.2004.11.021

B. Xi-margolis, S. S. Perry, J. A. Weitzel, D. H. Freel, C. D. Yoshida et al., A Role for PP1 in the Cdc2/Cyclin B-mediated Positive Feedback Activation of Cdc25, Molecular Biology of the Cell, vol.17, issue.4, pp.1779-89, 2006.
DOI : 10.1091/mbc.E05-08-0751

S. Matsuoka, Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase, Science, vol.282, issue.5395, pp.1893-1897, 1998.
DOI : 10.1126/science.282.5395.1893

A. G. Medentsev and V. K. Akimenko, Naphthoquinone metabolites of the fungi, Phytochemistry, vol.47, issue.6, pp.935-959, 1998.
DOI : 10.1016/S0031-9422(98)80053-8

L. Meijer, Le cycle de division cellulaire et sa régulation, Bulletin du cancer, vol.Hors série, pp.41-53, 2006.

&. Méjean and . Lebret, La cascade m??tastatique : angiogen??se et nouveaux concepts, Progr??s en Urologie, vol.18, pp.156-166, 2008.
DOI : 10.1016/S1166-7087(08)74538-X

V. Mersch-sundermann, S. Knasmüller, X. Wu, F. Darroudi, and F. Kassie, Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents, Toxicology, vol.198, issue.1-3, pp.1-3, 2004.
DOI : 10.1016/j.tox.2004.02.009

J. S. Mitchell, D. Brinkley, and J. L. Haybittle, Clinical Trial of Radiosensitizers, Including Synkavit and Oxygen Inhaled at Atmospheric Pressure, Acta Radiologica: Therapy, Physics, Biology, vol.83, issue.5, pp.329-370, 1965.
DOI : 10.1038/bjc.1953.30

S. Mizoguchi and K. H. Kim, Expression of cdc25 Phosphatases in the Germ Cells of the Rat Testis1, Biology of Reproduction, vol.56, issue.6, pp.1474-1481, 1997.
DOI : 10.1095/biolreprod56.6.1474

M. Molinari, C. Mercurio, J. Dominguez, F. Goubin, and G. F. Draetta, Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis, EMBO reports, vol.19, issue.1, pp.71-80, 2000.
DOI : 10.1128/MCB.19.9.6379

T. J. Monks, R. P. Hanzlik, G. M. Cohen, D. Ross, and D. G. Graham, Quinone chemistry and toxicity, Toxicology and Applied Pharmacology, vol.112, issue.1, pp.2-16, 1992.
DOI : 10.1016/0041-008X(92)90273-U

T. J. Monks and D. C. Jones, The Metabolism and Toxicity of Quinones, Quinonimines, Quinone Methides, and Quinone-Thioethers, Current Drug Metabolism, vol.3, issue.4, pp.425-438, 2002.
DOI : 10.2174/1389200023337388

M. Montes, E. Braud, M. A. Miteva, M. L. Goddard, O. Mondesert et al., Receptor-Based Virtual Ligand Screening for the Identification of Novel CDC25 Phosphatase Inhibitors, Journal of Chemical Information and Modeling, vol.48, issue.1, pp.157-165, 2008.
DOI : 10.1021/ci700313e

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, Journal of Immunological Methods, vol.65, issue.1-2, pp.55-63, 1983.
DOI : 10.1016/0022-1759(83)90303-4

U. Münchberg, A. Anwar, S. Mecklenburg, and C. Jacob, Polysulfides as Biologically Active Ingredients of Garlic, ChemInform, vol.5, issue.35, pp.1505-1523, 2007.
DOI : 10.1002/chin.200735239

J. Neidhart, D. Gochnour, R. Roach, D. Hoth, and D. Young, A comparison of mitoxantrone and doxorubicin in breast cancer., Journal of Clinical Oncology, vol.4, issue.5, pp.672-677, 1986.
DOI : 10.1200/JCO.1986.4.5.672

B. Xii-newman, D. J. Cragg, and G. M. , Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010, Journal of Natural Products, vol.75, issue.3, pp.311-335, 1981.
DOI : 10.1021/np200906s

Y. Nishikawa, B. I. Carr, M. Wang, S. Kar, F. Finn et al., Growth Inhibition of Hepatoma Cells Induced by Vitamin K and Its Analogs, Z.B. ; Kerns, J. ; & Naganathan, S. Journal of Biological Chemistry, vol.270, issue.47, pp.28304-28310, 1995.

E. Nissen, S. Tanneberger, H. Weiss, and E. Bender, [In vitro cultivation of vital tissue slices: a new variation of organ culture technics], Biomed Biochim Acta, vol.42, pp.7-8, 1983.

V. Noto, H. S. Taper, Y. H. Jiang, J. Janssens, J. Bonte et al., Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action, Cancer, vol.29, issue.5, pp.901-907, 1989.
DOI : 10.1177/29.9.7288160

K. Ollinger and A. Brunmark, Effect of hydroxy substituent position on 1,4- naphthoquinone toxicity to rat hepatocytes, J. Biol. Chem, vol.266, issue.32, pp.21496-21503, 1991.

S. Osbild, L. Brault, E. Battaglia, and D. Bagrel, Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells, Anticancer research, vol.26, pp.35953-600, 2006.

V. Papanikolaou, D. Iliopoulos, I. Dimou, S. Dubos, I. Tsougos et al., The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells, International journal of oncology, vol.35, issue.5, pp.1141-1150, 2009.

H. Peng, L. H. Zalkow, R. T. Abraham, and G. Powis, Novel CDC25A Phosphatase Inhibitors from Pyrolysis of 3-??-Azido-B-homo-6-oxa-4-cholesten-7-one on Silica Gel, Journal of Medicinal Chemistry, vol.41, issue.24, pp.4677-80, 1998.
DOI : 10.1021/jm980500r

Y. Pereg, B. Y. Liu, K. M. O-'rourke, M. Sagolla, A. Dey et al., Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A, Nature Cell Biology, vol.7, issue.4, pp.400-406, 2010.
DOI : 10.1038/ncb2041

L. Pu, A. A. Amoscato, M. E. Bier, and J. S. Lazo, Phase Inhibition by a Novel, Selective Cdc25 Inhibitor 7-Chloro-6-(2-morpholin-4-ylethylamino)- quinoline-5,8-dione, Journal of Biological Chemistry, vol.60, issue.49, pp.46877-46885, 2002.
DOI : 10.1038/379466a0

J. M. Rae, C. J. Creighton, J. M. Meck, B. R. Haddad, and M. D. Johnson, MDA-MB-435 cells are derived from M14 Melanoma cells??????a loss for breast cancer, but a boon for melanoma research, Breast Cancer Research and Treatment, vol.108, issue.2, pp.13-19, 2007.
DOI : 10.1007/s10549-006-9392-8

D. Ray, Y. Terao, P. G. Fuhrken, Z. Ma, F. J. Demayo et al., Deregulated CDC25A Expression Promotes Mammary Tumorigenesis with Genomic Instability, Cancer Research, vol.67, issue.3, pp.984-91, 2007.
DOI : 10.1158/0008-5472.CAN-06-3927

B. Xiii-raymond and É. , Le concept de cible en cancérologie, 2008.

R. A. Reynolds, A. W. Yem, C. L. Wolfe, M. R. Deibel, C. G. Chidester et al., Crystal structure of the catalytic subunit of Cdc25B required for G 2 /M phase transition of the cell cycle 1 1Edited by I. A. Wilson, Journal of Molecular Biology, vol.293, issue.3, pp.559-68, 1999.
DOI : 10.1006/jmbi.1999.3168

A. S. Romanova, A. V. Patudin, and A. I. Ban-'kovskii, Quinones of higher plants as possible therapeutic agents, Pharmaceutical Chemistry Journal, vol.11, issue.7, pp.927-937, 1977.

J. Rudolph, Redox Regulation of the Cdc25 Phosphatases, Antioxidants & Redox Signaling, vol.7, issue.5-6, pp.761-767, 2005.
DOI : 10.1089/ars.2005.7.761

P. Russell and P. Nurse, cdc25+ functions as an inducer in the mitotic control of fission yeast, Cell, vol.45, issue.1, pp.145-153, 1986.
DOI : 10.1016/0092-8674(86)90546-5

W. M. Russell and R. L. Bursch, The Principles of Humane Experimental Technique, p.238, 1959.

I. H. Russo and J. Russo, Mammary gland neoplasia in long-term rodent studies, Environmental Health Perspectives, vol.104, issue.9, pp.938-967, 1996.
DOI : 10.1289/ehp.96104938

N. E. Saidu, S. Valente, E. Bana, G. Kirsch, D. Bagrel et al., Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells, Bioorganic & Medicinal Chemistry, vol.20, issue.4, pp.1584-93, 2012.
DOI : 10.1016/j.bmc.2011.12.032

M. Sarkis, D. N. Tran, S. Kolb, M. A. Miteva, B. O. Villoutreix et al., Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: Effect of dimerisation on phosphatase inhibition, Bioorganic & Medicinal Chemistry Letters, vol.22, issue.24, pp.7345-50, 2012.
DOI : 10.1016/j.bmcl.2012.10.072

I. Fukai, M. Kiriyama, Y. Yamakawa, and Y. Fujii, Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer, Cancer letters, vol.173, issue.2, pp.187-92, 2001.

Y. Sato, H. Sasaki, S. Kondo, I. Fukai, M. Kiriyama et al., Expression of the cdc25B mRNA Correlated with that of N-myc in Neuroblastoma, Japanese Journal of Clinical Oncology, vol.31, issue.9, pp.428-459, 2001.
DOI : 10.1093/jjco/hye093

P. A. Savitsky and T. Finkel, Redox Regulation of Cdc25C, Journal of Biological Chemistry, vol.1176, issue.23, pp.20535-20575, 2002.
DOI : 10.1002/(SICI)1097-4652(199810)177:1<148::AID-JCP16>3.0.CO;2-9

C. Schorl and J. M. Sedivy, Analysis of cell cycle phases and progression in cultured mammalian cells, Methods, vol.41, issue.2, pp.143-150, 2007.
DOI : 10.1016/j.ymeth.2006.07.022

G. K. Schwartz and M. A. Shah, Targeting the Cell Cycle: A New Approach to Cancer Therapy, Journal of Clinical Oncology, vol.23, issue.36, pp.9408-9429, 2005.
DOI : 10.1200/JCO.2005.01.5594

B. Xiv-sexl, V. Diehl, J. A. Sherr, C. J. Ashmun, R. Beach et al., A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2, Oncogene, vol.18, issue.3, pp.573-82, 1999.
DOI : 10.1101/gad.8.15.1759

C. Shen, M. Gu, D. Liang, L. Miao, L. Hu et al., Establishment and characterization of three new human breast cancer cell lines derived from Chinese breast cancer tissues, Cancer Cell International, vol.9, issue.1, p.2, 2009.
DOI : 10.1186/1475-2867-9-2

Y. Shi, M. Moon, S. Dawood, B. Mcmanus, and P. P. Liu, Mechanismen und Management der Doxorubicinkardiotoxizt??t, Herz, vol.334, issue.4, pp.296-305, 2011.
DOI : 10.1124/jpet.110.170191

R. Shimazawa, M. Gochomori, and R. Shirai, Design and synthesis of novel Cdc25A-inhibitors having phosphate group as a hydrophilic residue, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.16, pp.4339-4381, 2004.
DOI : 10.1016/j.bmcl.2004.05.083

R. Shimazawa, T. Suzuki, K. Dodo, and R. Shirai, Design and synthesis of dysidiolide analogs from vitamin D3: novel class of Cdc25A inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.14, issue.12, pp.3291-3295, 2004.
DOI : 10.1016/j.bmcl.2004.03.100

E. Sibille, E. Bana, W. Chaouni, M. Diederich, D. Bagrel et al., Development of a matrix-assisted laser desorption/ionization???mass spectrometry screening test to evidence reversible and irreversible inhibitors of CDC25 phosphatases, Analytical Biochemistry, vol.430, issue.1, pp.83-91, 2012.
DOI : 10.1016/j.ab.2012.08.006

J. Sohn, B. Kiburz, Z. Li, L. Deng, A. Safi et al., Inhibition of Cdc25 Phosphatases by Indolyldihydroxyquinones, Journal of Medicinal Chemistry, vol.46, issue.13, pp.2580-2588, 2003.
DOI : 10.1021/jm0300835

H. D. Soule, J. Vazguez, A. Long, S. Albert, and M. Brennan, A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2, JNCI: Journal of the National Cancer Institute, vol.51, issue.5, pp.1409-1416, 1973.
DOI : 10.1093/jnci/51.5.1409

D. Spitkovsky, P. Jansen-dürr, E. Karsenti, and I. Hoffman, S-phase induction by adenovirus E1A requires activation of cdc25a tyrosine phosphatase, Oncogene, vol.12, issue.12, pp.2549-54, 1996.

K. Subik, L. Baxter, T. Strzepek, D. Costello, P. Crowley et al., The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines, Breast Cancer: Basic and Clinical Research, vol.1, pp.35-41, 2010.
DOI : 10.1158/1940-6207.CAPR-08-0037

M. Sui, Y. Huang, B. H. Park, N. E. Davidson, and W. Fan, Estrogen Receptor ?? Mediates Breast Cancer Cell Resistance to Paclitaxel through Inhibition of Apoptotic Cell Death, Cancer Research, vol.67, issue.11, pp.5337-5381, 2007.
DOI : 10.1158/0008-5472.CAN-06-4582

M. Takahashi, K. Dodo, Y. Sugimoto, Y. Aoyagi, Y. Yamada et al., Synthesis of the novel analogues of dysidiolide and their structure???activity relationship, Bioorganic & Medicinal Chemistry Letters, vol.10, issue.22, pp.2571-2574, 2000.
DOI : 10.1016/S0960-894X(00)00527-8

K. Talvinen, J. Tuikkala, J. Grönroos, H. Huhtinen, P. Kronqvist et al., Biochemical and clinical approaches in evaluating the prognosis of colon cancer, Anticancer research, vol.26, pp.4745-51

B. Tareen, J. L. Summers, J. M. Jamison, D. R. Neal, K. Mcguire et al., for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy, International Journal of Medical Sciences, vol.5, issue.2, pp.62-67, 2008.
DOI : 10.7150/ijms.5.62

S. Tate, Cell Cycle: Synchronization at Various Stages, Encyclopedia of life sciences, vol.126, 2005.
DOI : 10.1016/S1388-1981(01)00125-1

I. W. Taylor, P. J. Hodson, M. D. Green, and R. L. Sutherland, Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells, Cancer research, vol.43, issue.9, pp.4007-4010, 1983.

T. Terasima and L. J. Tolmach, Growth and nucleic acid synthesis in synchronously dividing populations of HeLa cells, Experimental Cell Research, vol.30, issue.2, pp.344-362, 1963.
DOI : 10.1016/0014-4827(63)90306-9

E. Thackery, The Gale Encyclopedia of cancer, 2002.

V. Vaira, G. Fedele, S. Pyne, E. Fasoli, G. Zadra et al., Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors, Proceedings of the National Academy of Sciences, vol.205, issue.2, pp.8352-8358, 2010.
DOI : 10.1016/j.mbs.2006.08.007

S. Valente, E. Bana, E. Viry, D. Bagrel, and G. Kirsch, Synthesis and biological evaluation of novel coumarin-based inhibitors of Cdc25 phosphatases, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.19, pp.5827-5830, 2010.
DOI : 10.1016/j.bmcl.2010.07.130

E. Vigo, H. Müller, E. Prosperini, G. Hateboer, P. Cartwright et al., CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase, Molecular and Cellular Biology, vol.19, issue.9, pp.6379-95, 1999.
DOI : 10.1128/MCB.19.9.6379

V. Vintonyak, H. Waldmann, and D. Rauh, Using small molecules to target protein phosphatases, Bioorganic & Medicinal Chemistry, vol.19, issue.7, pp.2145-55, 2011.
DOI : 10.1016/j.bmc.2011.02.047

E. Viry, A. Anwar, G. Kirsch, C. Jacob, M. Diederich et al., Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases, International Journal of Oncology, vol.38, issue.4, pp.1103-1111, 2011.

B. Xvi-van-vugt, M. A. Brás, A. Medema, and R. H. , Polo-like Kinase-1 Controls Recovery from a G2 DNA Damage-Induced Arrest in Mammalian Cells, Molecular Cell, vol.15, issue.5, pp.799-811, 2004.
DOI : 10.1016/j.molcel.2004.07.015

R. Wang, G. He, M. Nelman-gonzalez, C. L. Ashorn, G. E. Gallick et al., Regulation of Cdc25C by ERK-MAP Kinases during the G2/M Transition, Cell, vol.128, issue.6, pp.1119-1151, 2007.
DOI : 10.1016/j.cell.2006.11.053

S. C. Wang, S. H. Lin, L. K. Su, and M. C. Hung, Changes in BRCA2 expression during progression of the cell cycle. Biochemical and biophysical research communications, pp.247-251, 1997.

Z. Wang, C. G. Trope, V. A. Flørenes, Z. Suo, J. M. Nesland et al., Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes, BMC Cancer, vol.5, issue.1, p.233, 2010.
DOI : 10.1038/ncb994

S. Waxman and H. Bruckner, The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and ??-tocopherol, European Journal of Cancer and Clinical Oncology, vol.18, issue.7, pp.685-692, 1982.
DOI : 10.1016/0277-5379(82)90215-2

G. Weber, Y. Wagener, and D. Hansen-koenig, La mortalité au Luxembourg: évolution historique, situation actuelle et perspectives futures du système national de surveillance de la mortalité, 2010.

S. Wegener, Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C, European Journal of Cell Biology, vol.79, issue.11, pp.810-815, 2000.
DOI : 10.1078/0171-9335-00115

S. Wegener, W. Hampe, D. Herrmann, and H. C. Schaller, Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C, European Journal of Cell Biology, vol.79, issue.11, pp.810-815, 2000.
DOI : 10.1078/0171-9335-00115

W. Gang, H. Ying-yan, J. Jia, L. Jing-ya, L. Wei et al., Synthesis and biological evaluation of (?)-cryptotanshinone and its simplified analogues as potent CDC25 inhibitors, Tetrahedron, vol.61, issue.7

M. T. Weigel and M. Dowsett, Current and emerging biomarkers in breast cancer: prognosis and prediction, Endocrine Related Cancer, vol.17, issue.4, pp.245-62, 2010.
DOI : 10.1677/ERC-10-0136

W. M. Westerink and W. G. Schoonen, Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells Toxicology in vitro : an international journal published in association with, BIBRA, vol.21, issue.8, pp.1592-602, 2007.

R. D. Whelan, C. J. Waring, C. R. Wolf, J. D. Hayes, L. K. Hosking et al., Over-expression of P-glycoprotein and glutathione S-transferase PI in MCF-7 cells selected for vincristine resistancein vitro, International Journal of Cancer, vol.1, issue.2, pp.241-246, 1992.
DOI : 10.1128/MCB.5.8.2114

C. F. Woeller, D. D. Anderson, D. M. Szebenyi, and P. J. Stover, Evidence for Small Ubiquitin-like Modifier-dependent Nuclear Import of the Thymidylate Biosynthesis Pathway, Journal of Biological Chemistry, vol.277, issue.suppl., pp.17623-17631, 2007.
DOI : 10.1016/S0076-6879(97)77028-9

B. Xvii-woo, E. S. Rice, R. L. Lazo, and J. S. , Cell cycle dependent subcellular distribution of Cdc25B subtypes, Oncogene, vol.18, issue.17, pp.2770-2776, 1999.

F. Y. Wu, W. C. Liao, and H. M. Chang, Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays, Life Sciences, vol.52, issue.22, pp.1797-804, 1993.
DOI : 10.1016/0024-3205(93)90469-J

F. Y. Wu, -. Sun, and T. , Vitamin K3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase, European Journal of Cancer, vol.35, issue.9, pp.1388-1393, 1999.
DOI : 10.1016/S0959-8049(99)00156-2

D. Ye, Y. Zhang, F. Wang, M. Zheng, X. Zhang et al., Novel thiophene derivatives as PTP1B inhibitors with selectivity and cellular activity, Bioorganic & Medicinal Chemistry, vol.18, issue.5, pp.1773-82, 2010.
DOI : 10.1016/j.bmc.2010.01.055

L. M. Young and M. Pagano, Cdc25 phosphatases, Cell Cycle, vol.9, issue.23, pp.4613-4617, 2010.
DOI : 10.1158/0008-5472.CAN-07-2415

Y. Zhao, O. Haccard, R. Wang, J. Yu, J. Kuang et al., Roles of Greatwall Kinase in the Regulation of Cdc25 Phosphatase, Molecular Biology of the Cell, vol.19, issue.4, pp.1317-1344, 2008.
DOI : 10.1091/mbc.E07-11-1099

J. Zwicker, F. C. Lucibello, L. Wolfraim, C. Gross, M. Truss et al., Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression, Embo J, vol.14, issue.18, pp.4514-4522, 1995.